Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Neurogene Inc. (NGNE) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-20.95M |
|
-- |
|
-- |
|
$23.80M |
|
$-23.80M |
|
$2.85M |
|
$-20.95M |
|
$-20.95M |
|
$-20.95M |
|
$-20.95M |
|
$-20.95M |
|
$-20.95M |
|
$-23.80M |
|
$-23.84M |
|
21.17M |
|
21.17M |
|
$-0.99 |
|
$-0.99 |
|
| Balance Sheet Financials | |
$270.52M |
|
$13.48M |
|
$17.31M |
|
$287.83M |
|
$14.71M |
|
$0.01M |
|
$7.58M |
|
$22.29M |
|
$265.54M |
|
$265.54M |
|
$265.54M |
|
14.78M |
|
| Cash Flow Statement Financials | |
$-59.74M |
|
$-15.61M |
|
$9.77M |
|
$136.93M |
|
$71.34M |
|
$-65.58M |
|
$10.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.39 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-60.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.89% |
|
-7.89% |
|
-7.28% |
|
-7.89% |
|
$17.97 |
|
$-2.87 |
|
$-2.82 |
|